FIELD: organic chemistry. SUBSTANCE: products: peptide derivatives of the formula (I). Synthesis is carried out by oxidation of peptide derivative of the formula (II) followed by if necessary sulfoamination of compound where R3 - carboxy- or ester-group, conversion of carboxylic acid ester-group to the corresponding carboxy-group by hydrolysis. Pharmaceutical composition inhibiting human leukocyte elastase activity has derivatives of peptide (I) as an active substance at the dose 100-250 mg per unit and pharmaceutically acceptable carrier. Structure of compounds of the formulas (I) and (II) is given in description text. Synthesized compounds were used in pharmacology. EFFECT: improved method of synthesis. 4 cl, 2 tbl
Authors
Dates
1996-01-27—Published
1986-01-21—Filed